![Kory Wentworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kory Wentworth
Finanzdirektor/CFO bei
ENTRADA THERAPEUTICS, INC.
Vermögen: 106 997 $ am 31.05.2026
Profil
Kory James Wentworth currently works at Entrada Therapeutics, Inc., as Chief Financial Officer & Treasurer from 2020.
Mr. Wentworth also formerly worked at Alexion Pharmaceuticals, Inc., as Executive Director & Corporate Controller in 2017, bluebird bio, Inc., as Treasurer & Vice President-Finance in 2020, and PricewaterhouseCoopers LLP, as Audit Manager from 2002 to 2008.
Mr. Wentworth received his undergraduate degree from Susquehanna University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.04.2026 | 15’134 ( 0.04% ) | 106 997 $ | 31.05.2026 |
Aktive Positionen von Kory Wentworth
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.11.2020 |
Ehemalige bekannte Positionen von Kory Wentworth
| Unternehmen | Position | Ende |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 08.09.2020 |
| ALEXION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.12.2017 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Comptroller/Controller/Auditor | 01.12.2008 |
Ausbildung von Kory Wentworth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Susquehanna University
 Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
